Cushing's Patients' Pituitary Tumor Shrinks With Signifor: Review... - Cushing's Disease News
8/5/2022 12:00:00 AM2 years 8 months ago
by Steve Bryson, PhD, Steve Bryson, PhD
by Steve Bryson, PhD, Steve Bryson, PhD
Signifor (pasireotide) sizably shrinks benign pituitary tumors in more than 40% of Cushing’s disease patients, according to a review study.
Signifor (pasireotide), a treatment for Cushings disease patients for whom surgery failed or is not an option, significantly reduces the size of benign pituitary tumors in more than 40% of people wit… [+4627 chars]
full article...